Based on this and on our findings that PAK4 inhibition restored senescence in breast cancer, PAK4 inhibition may be explored as a potential therapeutic strategy for breast cancer, the most frequently diagnosed cancer in women world-wide and one of the major causes of lethality.12 This evidence concerns the gene PAK4 and breast cancer.